dacarbazine has been researched along with Lymphoma, T-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrillo, JA; Gill, JM; Kesari, S; Nguyen, M; Sharma, A; Truong, J; Wagle, N; Yalamanchi, M | 1 |
| Hotta, T; Shimoyama, M; Tobinai, K; Tsukasaki, K | 1 |
1 review(s) available for dacarbazine and Lymphoma, T-Cell
| Article | Year |
|---|---|
Lymphoma study group of JCOG.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Approval; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Japan; Kaplan-Meier Estimate; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Molecular Targeted Therapy; Multiple Myeloma; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Vincristine | 2012 |
1 other study(ies) available for dacarbazine and Lymphoma, T-Cell
| Article | Year |
|---|---|
Successful and durable response of primary CNS T-cell lymphoma to upfront temozolomide monotherapy.
Topics: Central Nervous System Neoplasms; Dacarbazine; Humans; Lymphoma, T-Cell; Temozolomide | 2021 |